Abstract
About 35 years ago human papillomaviruses (HPV) have been suggested as causative agent for cervical cancer whose infectious etiology had been suggested already many years before. The discovery of the plurality of HPVs encompassing a variety of types with particular biologic properties, the regular presence of the genomes of the so called high-risk types within tumor biopsies, the awareness about the transforming potential of the viral proteins and informative epidemiological surveys led to the consenting view of a causative link between these viruses and cervical cancer and ultimately triggered the development of HPV-specific vaccines for prevention of cervical cancer.
Keywords: Papillomaviruses, heterogeneity, cervical cancer, molecular cloning, epidemiology
Current Cancer Therapy Reviews
Title: The Discovery of HPV and its Clinical Implications
Volume: 6 Issue: 2
Author(s): Lutz Gissmann
Affiliation:
Keywords: Papillomaviruses, heterogeneity, cervical cancer, molecular cloning, epidemiology
Abstract: About 35 years ago human papillomaviruses (HPV) have been suggested as causative agent for cervical cancer whose infectious etiology had been suggested already many years before. The discovery of the plurality of HPVs encompassing a variety of types with particular biologic properties, the regular presence of the genomes of the so called high-risk types within tumor biopsies, the awareness about the transforming potential of the viral proteins and informative epidemiological surveys led to the consenting view of a causative link between these viruses and cervical cancer and ultimately triggered the development of HPV-specific vaccines for prevention of cervical cancer.
Export Options
About this article
Cite this article as:
Gissmann Lutz, The Discovery of HPV and its Clinical Implications, Current Cancer Therapy Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339410791202538
DOI https://dx.doi.org/10.2174/157339410791202538 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Applications of Liposomal Based Drug Delivery and Drug Targeting for Immune Linked Inflammatory Maladies: A Contemporary View Point
Current Drug Targets Lipid Based Nanosystems for Curcumin: Past, Present and Future
Current Pharmaceutical Design Oxidative Stress and its Clinical Consequences: Relationship between Diabetes and Cancer
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry MicroRNAs in Lung Cancer and Lung Cancer Bone Metastases: Biomarkers for Early Diagnosis and Targets for Treatment
Recent Patents on Anti-Cancer Drug Discovery Polyphenols Counteract Tumor Cell Chemoresistance Conferred by Multidrug Resistance Proteins
Anti-Cancer Agents in Medicinal Chemistry Radiation Therapy in the Early 21st Century: Technological Advances
Current Cancer Therapy Reviews Design, Synthesis, Molecular Docking, and Anticancer Evaluation of Pyrazole Linked Pyrazoline Derivatives with Carbothioamide Tail as EGFR Kinase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Copper(II) Complexes with Saccharinate and Glutamine as Antitumor Agents: Cytoand Genotoxicity in Human Osteosarcoma Cells
Anti-Cancer Agents in Medicinal Chemistry Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery
Current Cancer Drug Targets Critical Role of Hypoxia Sensor - HIF-1α in VEGF Gene Activation. Implications for Angiogenesis and Tissue Injury Healing
Current Medicinal Chemistry Epothilones: A Novel Class of Non-taxane Microtubule-stabilizing Agents
Current Pharmaceutical Design Antimicrobial Peptides and Peptidomimetics - Potent Therapeutic Allies for Staphylococcal Infections
Current Pharmaceutical Design ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Current Pharmaceutical Design Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry Sphingolipid Metabolism and Drug Resistance in Hematological Malignancies
Anti-Cancer Agents in Medicinal Chemistry Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry
Current Medicinal Chemistry Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
Current Drug Targets Recent Advances in Copper Radiopharmaceuticals
Current Radiopharmaceuticals Predictors and Clinical Implications of HPV Reservoire Districts for Genital Tract Disease
Current Pharmaceutical Design Progress in the Development of Selective Inhibitors of Aurora Kinases
Current Topics in Medicinal Chemistry